CRP and infection: Beyer et al. conducted a double blind randomized controlled trial using piroxicam versus placebo in geriatric patients over the age of 70 who were hospitalized with infection-induced inflammation (characterized by C-reactive protein (CRP) serum level > 10 mg/L and/or fibrinogen > 400 mg/dL)[43].